Despite black box warnings from the FDA regarding echocardiography contrast agents, studies have consistently confirmed their safety. Now, a meta-analysis published July 23 in the American Journal of Cardiology further supports that these agents do not increase incidences of either myocardial infarction (MI) or death.
Written by Lisa Fratt
Integrating calcium scoring into the emergency department workup of low-risk chest pain patients may cut costs and reduce missed myocardial infarctions, according to research presented at the Society of Cardiac Computed Tomography (SCCT) conference in July.
Imaging with stress cardiac MRI in an observation unit can reduce incident cost without missing acute coronary syndrome in patients with emergent chest pain when compared to inpatient care, according to a study published online May 31 in the Annals of Emergency Medicine.
In vivo 3T MRI can detect features of vulnerable plaques in an animal model of controlled atherothrombosis and MRI may be used as a noninvasive modality for the identification of plaques that are prone to disruption, according to a study published in the May issue of Circulation: Cardiovascular Imaging.
According to a recent article published online in the May 12 edition of the New England Journal of Medicine, policymakers attempting to control Medicare costs by reducing differences in Medicare spending across geographic areas need better information about the specific source of the differences.
Written by Manjula Puthenedam
A significant reduction in cardiac events was observed in patients with 18F-FDG PET–assisted management, compared with patients who received standard care in an experienced center with ready access to 18F-FDG and integration with imaging, heart failure and revascularization teams, according to research published in the April issue of the Journal of Nuclear Medicine.
Written by Gina Narcisi
ATLANTA -- Diabetic patients would be the most likely candidates for early coronary artery disease (CAD) screening via imaging testing because this patient population is considered at high risk for myocardial infarction or cardiac death, said Gary Heller MD, director of cardiology at Hartford Hospital in Hartford, Conn., during a session yesterday at the American College of Cardiology (ACC) annual conference.
Publicly released report cards that rely heavily on the evaluation of hospitals do not significantly improve patient care, according to a study published Nov. 18 in the Journal of American Medical Association.
Increased FDG uptake in major arteries emerged as a strong predictor of a subsequent vascular event, according to a study in this month’s Journal of Nuclear Medicine.
Coronary artery calcium scoring appears to foster efficient selective testing patterns among asymptomatic individuals at risk for cardiovascular disease, according to the prospective EISNER trial published Sept. 29 in the Journal of the American College of Cardiology.
The use of contrast agents during stress echocardiography does not lead to short- or long-term risk of death or myocardial infarction, according to a study in the September issue of the Journal of the American College of Cardiology: Cardiovascular Imaging.
Cardiac MR showed a large, systematic improvement over transthoracic echocardiography in measuring volumes, left ventricular ejection fraction and wall motion abnormality despite moderate inter-modality correlations after a myocardial infarction, according to a study published Aug. 18 in Cardiovascular Ultrasound.
Ultrasound can be used to determine a patient's cardaic event risk after a transient ischemic attack (TIA). An evaluation of transcranial and extracranial Doppler ultrasonography, published July 30 in BMC Medical Imaging, demonstrated that both future stroke and future cardiovascular ischemic events can be predicted by abnormal findings.
Since the Appropriateness Criteria for cardiac CT (CCT) was published in 2006, the modality has experienced rapid growth in technology and clinical use. When the American College of Cardiology (ACC) formally reviews the criteria next year, there might be room to add more indications to the "appropriate" category, including the "triple rule-out" exam, according to a study presented at the Society of Cardiovascular Computed Tomography (SCCT) meeting in Orlando, Fla., last week.
Pharmalucence, a supplier of radiopharmaceutical products, has received approval from the FDA's Office of Generic Drugs for its abbreviated new drug application to manufacture and market its kit for the preparation of technetium Tc-99m Sestamibi injection.
Boston Scientific has received FDA approval to market its Taxus Liberte Long paclitaxel-eluting coronary stent system, a drug-eluting stent (DES) designed for long lesions.
The use of a 3D inversion recovery gradient-recalled echo sequence at 3T MRI allows accurate assessment of myocardial infarction without loss of contrast-to-noise ratio compared with a standard 2D technique, according to research published this month in the American Journal of Roentgenology.
Fifty percent of patients with acute chest pain and low-to-intermediate likelihood of acute coronary syndrome (ACS) were free of coronary artery disease by CT and had no ACS, according to ROMICAT trial results published in the May 5 issue of the Journal of the American College of Cardiology.
Converting physician's notes into electronic documentation earlier in the typical implementation cycle for an inpatient EHR would give hospitals a more complete information base for quality management, according to a white paper from Computer Sciences Corp. (CSC), a Falls Church, Va.-based consulting firm.
The role of MR perfusion imaging in clinical decision making is being refined, based on new techniques that allow measuring blood flow to the heart with better spatial resolution and without any ionizing radiation, according to a presentation at the 12th annual scientific sessions of the Society for Cardiovascular Magnetic Resonance (SCMR) last week in Orlando, Fla.
|